White Papers

Provided By:

Rx EDGE Pharmacy Networks

February 9, 2017

Today’s consumers have choices about how and where they gather pertinent health information, and conversely, pharmaceutical companies have endless options on how, when and where to reach them. The plethora of options introduces a new quandary—where to begin? This white paper … Read More »

Provided By:

inVentiv Health

January 31, 2017

Through sustained partnerships between advocacy and industry, the US and Europe can overcome barriers to care. As a source of human suffering, a barrier to workplace productivity, a burden on families and a driver of medical costs, mental illness amounts to an unparalleled p … Read More »

Provided By:

Atlantis Healthcare

December 15, 2016

A stand-out digital solution is one that is highly valued by the patient, seamlessly integrated, and delivers measurable results, such as improved health outcomes. Learn about an established process and infrastructure to design, implement and measure digital tools. Increasin … Read More »

Provided By:

Sciformix Corporation

December 1, 2016

While development of promising new products is an obvious area of focus for biopharmaceutical companies, maintenance of already established marketed products is a critical activity that cannot be ignored. As products mature, there is high pressure to grow or sustain revenue … Read More »

Provided By:

eyeforpharma

November 14, 2016

GSK’s move to a new model of customer engagement has generated a great deal of debate. Indeed, many commentators remain skeptical that this ‘ethical’ model – especially the decoupling of sales incentives from prescription volume isn’t robust enough to deliver results in the … Read More »

Provided By:

Atlantis Healthcare

October 19, 2016

The self-management challenges for people living with chronic conditions are broad and are influenced by a range of factors, both internal and external to the individual. This report outlines how when designing support systems and programs to aid self-management, it is impor … Read More »

Provided By:

Chiltern

October 3, 2016

To manage chronic medical conditions, real-time monitoring of disease-specific physiologic metrics is becoming an important part of standard of care, and smartphone technology is making it possible. Existing smartphone interfacing devices now record health parameters and met … Read More »

Provided By:

Cognizant

September 27, 2016

The rise of generic medicines, regulatory pressure, and rampant consumer adoption of technology demands that the life sciences industry adopt a more direct and value-driven engagement to remain competitive. Harnessing digital technology allows you to meet these new industry … Read More »

Provided By:

Manatt Health

September 13, 2016

While the Affordable Care Act continues to be politically polarizing, stakeholders from across the health reform landscape are focused on effectively implementing the law and on making incremental – not radical – changes to it. The question is how such change might happen gi … Read More »

Provided By:

myClin

August 30, 2016

Regulatory scrutiny in clinical research has intensified in recent years, and there are no signs that the intensity of the regulatory environment is abating. In the context of increased outsourcing of clinical study activity to CROs, inspectors are showing an increased inter … Read More »

Provided By:

C3i Healthcare Connections

August 29, 2016

Findings reveal that based on the industry’s current level of participation in social media, utilization of technology, and effectiveness of social programs, the pharma industry is in the early stages of social media maturity. In fact, only 13% of those that participated in … Read More »

Provided By:

Cello Health

August 15, 2016

An estimated 400 million people worldwide are currently living with rare diseases. There are approximately 7,000 different types of rare diseases and disorders, with more being discovered every day. At best, the knowledge base about any individual rare disease is small, frag … Read More »

Provided By:

Schulman IRB

July 28, 2016

Managing an efficient, well-organized start-up phase is critical to overall study success. While IRB review is just one element of the study start-up process, the IRB can play a crucial role in reaching key study milestones in multisite clinical trials for sponsors, CROs and … Read More »

Provided By:

TrialCard

July 28, 2016

If you have ever worked with Orphan Drugs, you know finding appropriate patients is a major commercial challenge. Pharmaceutical sponsors of Orphan Drugs often lack the infrastructure and capabilities necessary to identify physicians who diagnose, treat, and manage these rar … Read More »

Provided By:

Health Perspectives Group

July 6, 2016

Do men and women trust the biopharmaceutical industry? How do the genders agree and disagree on this topic?  The results of two recent surveys paint a concerning picture, yet also show ways the industry can impact these opinions. This analysis reveals how men and women prefe … Read More »

Provided By:

Medidata

June 1, 2016

Research shows that data errors—missed adverse events, data anomalies and procedural deviations— can lead to costly study delays. Data errors are harder to spot as trials become more complex, which means standard practices for evaluating protocols and clinical data need to i … Read More »

Provided By:

Medidata

June 1, 2016

Clinical investigators rely on you to provide timely and accurate reimbursements. But it’s not always easy to keep up. Simplify the process using your existing EDC system, which already stores the data you need to set up and calculate site payments. Turn your traditional EDC … Read More »

Provided By:

Publicis Health

June 1, 2016

Together, technological advancements and tectonic shifts in the healthcare delivery model are pushing us toward an emerging health economy in which pharma marketers increasingly focus their efforts on each patient as a “Segment of One.” In this new segment-of-one model, busi … Read More »

Provided By:

TrialCard

April 28, 2016

Those who run co-pay programs often see them as absolute–something they employ as part of their strategy, and from which the impact is easily understood. The reality is, however, that co-pay programs work to varying degrees. Simply having one will attract more patients, but … Read More »

Provided By:

eClinical Solutions

March 17, 2016

Leveraging clinical trial data to decrease risk, time, and cost. Clinical trial data is critical to bring new treatments to market quickly and in a cost-effective manner. Clinical trial data is the most valuable asset for life sciences companies. However, companies struggle … Read More »

Provided By:

Guidemark Health

February 29, 2016

There are three valuable benefits of using behavioral insights when planning a marketing program. First, they provide validated models for better predicting human behavior, as opposed to personal opinions or guesswork. Second, they reveal how non-rational and non-conscious f … Read More »

FEEDBACK